GW Medical Technologies Announces Study Team for Its Phase II Alzheimer's Blood Diagnostic Test.LymPro Test[R] Could Bring Faster Diagnosis, Treatment PHOENIX -- GW Medical Technologies LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control was recently awarded a $1,036,000 Phase II SBIR SBIR Small Business Innovation Research (program/grant) SBIR Space Based Infra-Red SBIR Speaker-Boundary Interference SBIR Site Backsurface-referenced Ideal Plane/Range (silicon wafers) Grant from the National Institute on Aging The National Institute on Aging is a division of the U.S. National Institutes of Health, located in Bethesda, Maryland. Formed in 1974, NIA's mission is to improve the health and well-being of older Americans through research. It is the primary U.S. , a division of the National Institutes of Health. The grant will assist GW Medical to further develop, refine and commercialize its new LymPro Test([R]), a blood diagnostic test for early detection of Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. (AD). To accomplish this task, GW Medical Technologies has assembled a world-class team for their Phase II study effort. "We are very excited about the collaborative relationships we are structuring for this study. Thus far, we have two renowned Alzheimer's disease research organizations - Sun Health Research Institute and Pivotal Research Centers -- that will be assisting us in our patient recruitment efforts," says William Gartner, GW Medical's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "We also are extremely pleased to announce receipt of our final IRB IRB See: Industrial Revenue Bond approval for the study protocol and several of our key clinical sites." According to Dr. Joseph Rogers, Ph.D., president and senior scientist at Sun Health Research Institute, "The potential behind an early Alzheimer's disease diagnostic would be life changing for those individuals and families affected by this disease. As such, we are very excited about being part of the collaborative effort in advancing GW Medical's LymPro Test as a potential adjunctive AD diagnostic tool for clinicians." Dr. Louis Kirby, M.D., medical director for Pivotal Research Centers, agrees; "Pivotal Research is pleased to be part of the study team in assisting GW Medical in their Phase II clinical trials. A new test to diagnose Alzheimer's disease earlier, such as their LymPro Test, could lead to expedited therapeutic intervention and an improved quality of life for those individuals affected by AD." "We are very much looking forward to beginning this study effort," says Dr. Prakash Rao, GW Medical vice president, chief science officer and principal investigator for this study. "Over 225 subjects will be recruited from a broad-based population mix of AD, non-AD and cognitively intact cohorts. Upon successful completion of this pivotal study effort, we fully anticipate being able to introduce our LymPro Test to the public as the first blood diagnostic test in the market to help physicians in their efforts in expediting the diagnosis of this devastating dev·as·tate tr.v. dev·as·tat·ed, dev·as·tat·ing, dev·as·tates 1. To lay waste; destroy. 2. To overwhelm; confound; stun: was devastated by the rude remark. disease," says Dr. Rao. About GW Medical Technologies LLC GW Medical Technologies LLC, a Phoenix-based company focused on the diagnosis of Alzheimer's disease, is poised to bring the LymPro Test[R] to market as fast as possible with U.S. and global approvals. Established in 2003 by William Gartner, GW Medical is privately held by founders and limited outside investors. For more information, please visit www.gwmedtech.com, or call 602-265-7862. About Sun Health Research Institute The Sun Health Research Institute is a private, non-profit biomedical research center dedicated to the study of age-related diseases. The Institute maintains collaborations with nationally-recognized institutions such as Johns Hopkins, Boston University and the University of Washington, and has adjunct faculty, graduate student and scientific ties with Arizona State University Arizona State University, at Tempe; coeducational; opened 1886 as a normal school, became 1925 Tempe State Teachers College, renamed 1945 Arizona State College at Tempe. Its present name was adopted in 1958. , the University of Arizona (body, education) University of Arizona - The University was founded in 1885 as a Land Grant institution with a three-fold mission of teaching, research and public service. , the Mayo Clinic, Scottsdale, TGEN TGEN Traffic Generator TGEN Table Generate TGEN Test Generator , Good Samaritan Hospital Good Samaritan Hospital may refer to: In the United States:
About Pivotal Research Centers Pivotal Research Centers is one of the largest and most successful clinical research organizations in the nation. Pivotal Research has extensive experience in multiple therapeutic areas with a focus in neurological, psychiatric, and selected internal medicine indications. Established in 1993, Pivotal Research Centers has successfully completed over 450 research studies in over 20 indications. For more information, please visit www.pivotalresearch.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion